Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1808570 | 0.80 | CYP1A2 (0.39) | CYP1A2CYP2D6MAPTKDM4EALDH1A1 | |
| SCHEMBL1806019 | 0.79 | TRPV1 (0.36) | TRPV1CYP1A2CYP2D6KDM4EALDH1A1 | |
| SCHEMBL1805935 | 0.76 | PDE4D (0.46) | TRPV1MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL21598933 | 0.69 | CYP1A2 (0.42) | TRPV1CYP1A2CYP2D6MAPTKDM4E | |
| SCHEMBL8567845 | 0.65 | KDM4E (0.43) | TRPV1CYP1A2CYP2D6MAPTKDM4E | |
| SCHEMBL1806339 | 0.62 | OPRL1 (0.46) | MEN1KMT2AKDM4ESLC6A4 | |
| SCHEMBL30395513 | 0.62 | ALDH1A1 (0.43) | TRPV1CYP1A2CYP2D6MAPTMEN1 | |
| SCHEMBL1808962 | 0.61 | TTR (0.37) | MAPTMEN1KMT2AALDH1A1P2RX7 | |
| SCHEMBL904436 | 0.61 | — | — | |
| SCHEMBL29674390 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2501703-A1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | Eli Lilly and Company (US) | 2012-09-26 | — | — | EP | disclosed |
| WO-2011060035-A1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |